Search

Your search keyword '"Quesada-Charneco, M."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Quesada-Charneco, M." Remove constraint Author: "Quesada-Charneco, M."
37 results on '"Quesada-Charneco, M."'

Search Results

2. Cambios en marcadores del metabolismo óseo y parámetros ultrasónicos en mujeres postmenopáusicas inducidos por isoflavonas de soja

3. Retos diagnósticos del metabolismo fosfocálcico en una misma paciente

4. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

8. Hiperparatiroidismo primario en situaciones especiales: síndromes de neoplasia endocrina múltiple y cáncer de paratiroides

9. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

10. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

14. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause

16. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

17. T1DiabetesGranada: a longitudinal multi-modal dataset of type 1 diabetes mellitus.

18. Factors Predicting the Response to a Vitamin D-Fortified Milk in Healthy Postmenopausal Women.

19. Effects of Daily Intake of Calcium and Vitamin D-Enriched Milk in Healthy Postmenopausal Women: A Randomized, Controlled, Double-Blind Nutritional Study.

20. [Lixisenatide in patients with type 2 diabetes and obesity: Beyond glycaemic control].

21. Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.

22. Analysis of vitamin D deficiency in calcium stone-forming patients.

23. Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.

24. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.

25. Cardiovascular risk factors in patients with asymptomatic primary hyperparathyroidism.

26. Recurrent renal colic - A case study.

27. Association of severe calcium lithogenic activity and bone remodeling markers.

28. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.

29. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.

30. [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial].

31. [Urea as therapeutic option for the treatment of the syndrome of inappropriate antidiuretic hormone secretion].

32. [Primary hyperparathyroidism in special situations: multiple endocrine neoplasia syndromes and parathyroid cancer].

33. Dramatic response to cholestyramine in a patient with Graves' disease resistant to conventional therapy.

34. [Usefulness of bone densitometry in the evaluation of primary hyperparathyroidism].

35. [Elevation of muscular enzymes and idiopathic hypoparathyroidism].

37. [Localization techniques in primary hyperparathyroidism].

Catalog

Books, media, physical & digital resources